L&C Bio Co. Ltd Capital Reinvestment Ratio
L&C Bio Co. Ltd capital reinvestment ratio. L&C Bio Co. Ltd (290650) has a Capital Reinvestment Ratio of 0.82x as of September 2025, meaning it reinvests 1% of its operating cash flow (₩3.79 Billion) in capital expenditures (₩3.10 Billion). See L&C Bio Co. Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of L&C Bio Co. Ltd (2017–2021)
Capital reinvestment ratio of L&C Bio Co. Ltd from 2017 to 2021. This chart tracks L&C Bio Co. Ltd's Capital Reinvestment Ratio across 5 annual periods. See 290650 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
L&C Bio Co. Ltd Capital Reinvestment Ratio by Year (2017–2021)
L&C Bio Co. Ltd capital reinvestment ratio by year from 2017 to 2021. For the full cash flow conversion analysis, see cash efficiency ratio of L&C Bio Co. Ltd.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.94x | ₩10.91 Billion | ₩10.25 Billion | ▲ +131.2% |
| 2020 | 0.41x | ₩7.42 Billion | ₩3.02 Billion | ▲ +33.6% |
| 2019 | 0.30x | ₩6.43 Billion | ₩1.96 Billion | ▼ -75.3% |
| 2018 | 1.23x | ₩3.85 Billion | ₩4.74 Billion | ▲ +1548.9% |
| 2017 | 0.07x | ₩3.82 Billion | ₩285.34 Million | — |